Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ivabradine Treatment on Exercise Capacity in Patients With Cardiac Allograft Vasculopathy After Heart Transplantation

NCT03405831 is registered in ClinicalTrials.gov with Finn Gustafsson as lead sponsor.

NCT NCT03405831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ivabradine Treatment on Exercise Capacity in Patients With Cardiac Allograft Vasculopathy After Heart Transplantation
Lead sponsor
Finn Gustafsson
Phase
Phase 4
Overall status
Unknown status
Start date
April 17, 2018
Completion date
December 31, 2019
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy, transplanted heart complication